Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.
Please read the tutorial at this link: https://ebookbell.com/faq
We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.
For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.
EbookBell Team
0.0
0 reviews
ISBN 10: 0824747763
ISBN 13: 9780824747763
Author: Jonathan Towne, Larry Hollier
Substantially revised to reflect the most recent surgical techniques and practices, this reference describes the most effective strategies to prevent, identify, and manage complications in vascular surgery-guiding surgeons through patient selection; instances of entrapment, malpositioning, and rupture; emerging endovascular treatments; and specific device-related complications.
1: PITFALLS OF NONINVASIVE VASCULAR TESTING
I. CLASSIFICATION OF THE PITFALLS OF NONINVASIVE TESTING
II. PROCEDURAL PITFALLS
III. INTERPRETATIVE AND STATISTICAL PITFALLS
IV. PERIPHERAL ARTERIAL TESTING
V. CEREBROVASCULAR TESTING
VI. PERIPHERAL VENOUS TESTING
VII. GOALS OF VASCULAR TESTING
REFERENCES
2: CARDIOPULMONARY COMPLICATIONS RELATED TO VASCULAR SURGERY
I. INTRODUCTION
II. CARDIAC COMPLICATIONS
III. PULMONARY COMPLICATIONS
IV. CONCLUSION
REFERENCES
3: RENAL FAILURE AND FLUID SHIFTS FOLLOWING VASCULAR SURGERY
I. THE INCIDENCE OF ACUTE RENAL FAILURE ASSOCIATED WITH VASCULAR SURGERY
II. NORMAL RENAL FUNCTION
III. FLUID SHIFTS ASSOCIATED WITH VASCULAR SURGERY
IV. CATEGORIES OF RENAL DYSFUNCTION
V. STRATEGIES TO PROTECT RENAL FUNCTION
VI. DIAGNOSIS AND TREATMENT OF RENAL DYSFUNCTION
VII. ESTABLISHED RENAL DYSFUNCTION AFTER VASCULAR SURGERY
REFERENCES
4: INTIMAL HYPERPLASIA: THE MECHANISMS AND TREATMENT OF THE RESPONSE TO ARTERIAL INJURY
I. AUTOLOGOUS VEIN GRAFT HEALING
II. PROSTHETIC GRAFT HEALING
III. ARTERIAL HEALING FOLLOWING BALLOON ANGIOPLASTY AND STENTING
IV. MOLECULAR MECHANISMS OF INTIMAL HYPERPLASIA
V. THERAPEUTIC APPROACHES TO INTIMAL HYPERPLASIA
VI. CONCLUSIONS
REFERENCES
5: THE HEALING CHARACTERISTICS, DURABILITY, AND LONG-TERM COMPLICATIONS OF VASCULAR PROSTHESES
I. DACRON GRAFTS
II. EXPANDED PTFE GRAFTS
III. POLYURETHANE
IV. BIOLOGICAL GRAFTS
2. Healing Characteristics
V. CONCLUSION
REFERENCES
6: ANASTOMOTIC ANEURYSMS
I. ETIOLOGY AND PATHOGENESIS
II. INCIDENCE
III. CLINICAL PRESENTATION AND DIAGNOSIS
IV. MANAGEMENT
VI. PREVENTION
REFERENCES
7: HYPERCOAGULABLE STATES AND UNEXPLAINED VASCULAR GRAFT THROMBOSIS
I. HEPARIN-INDUCED THROMBOSIS
II. STRATEGIES FOR PATIENTS WITH HEPARIN-INDUCED PLATELET AGGREGATION
III. ANTITHROMBIN DEFICIENCY
IV. DEFECTS IN THE FIBRINOLYTIC SYSTEM
VI. PROTEIN S DEFICIENCY
VII. ANTIPHOSPHOLIPID ANTIBODIES
VIII. ACTIVATED PROTEIN C RESISTANCE
IX. HYPERHOMOCYSTEINEMIA
X. UNEXPLAINED THROMBOSIS-GUIDELINE FOR IDENTIFYING HYPERCOAGULABLE PATIENTS
REFERENCES
8: COMPLICATIONS AND FAILURES OF ANTICOAGULANT AND ANTITHROMBOTIC THERAPY
I. UNFRACTIONATED HEPARIN
II. LOW-MOLECULAR-WEIGHTS HEPARINS
III. VITAMIN K ANTAGONISTS
IV. DIRECT THROMBIN INHIBITORS
V. FACTOR XA INHIBITORS
VI. PLATELET FUNCTION INHIBITORS
REFERENCES
9: GASTROINTESTINAL AND VISCERAL ISCHEMIC COMPLICATIONS OF AORTIC RECONSTRUCTION
I. CLASSIFICATION
II. ANATOMY AND PATHOPHYSIOLOGY
III. CLINICAL MANIFESTATIONS AND DIAGNOSIS
IV. ISCHEMIC COLITIS FOLLOWING STENT-GRAFT REPAIR OF ABDOMINAL AORTIC ANEURYSMS
V. PREVENTION
VI. ARTERIOGRAPHY
VII. OPERATIVE TECHNIQUES AND TREATMENT
VIII. SUMMARY
REFERENCES
10: SPINAL CORD ISCHEMIA
I. ANATOMY
II. PHYSIOLOGY OF ISCHEMIA
III. DETERMINANTS OF SPINAL CORD ISCHEMIA
IV. DETECTION OF SPINAL CORD ISCHEMIA
V. PREVENTION
VI. SUMMARY
REFERENCES
11: IMPOTENCE FOLLOWING AORTIC SURGERY
I. PHYSIOLOGY OF ERECTION
II. DIAGNOSIS
III. HISTORY
IV. CONCLUSION
REFERENCES
12: COMPLICATIONS FOLLOWING RECONSTRUCTIONS OF THE PARARENAL AORTA AND ITS BRANCHES
I. INTRODUCTION
II. OPERATIONS ON THE JUXTA- AND SUPRARENAL AORTA
III. COMPLICATIONS
IV. CONCLUSIONS
REFERENCES
13: COMPLICATIONS OF MODERN RENAL REVASCULARIZATION
I. PATIENT SELECTION
II. PERIPROCEDURAL COMPLICATIONS
REFERENCES
14: THE DIAGNOSIS AND MANAGEMENT OF AORTIC BIFURCATION GRAFT LIMB OCCLUSIONS
I. INCIDENCE
II. ETIOLOGY
III. DIAGNOSIS AND EVALUATION
IV. MANAGEMENT OF THE OCCLUDED LIMB
V. RESULTS
VI. SUMMARY
REFERENCES
15: PROBLEMS RELATED TO EXTRA-ANATOMIC BYPASS—INCLUDING AXILLOFEMORAL, FEMOROFEMORAL, OBTURATOR, AND THORACOFEMORAL BYPASSES
I. AXILLOFEMORAL BYPASS
II. FEMOROFEMORAL GRAFT
III. OBTURATOR BYPASS
IV. THORACOFEMORAL BYPASS
V. CONCLUSION
REFERENCES
16: VASCULAR GRAFT INFECTIONS: EPIDEMIOLOGY, MICROBIOLOGY, PATHOGENESIS, AND PREVENTION
I. EPIDEMIOLOGY
II. BACTERIOLOGY
III. PATHOGENESIS
IV. PREVENTION
REFERENCES
17: AORTIC GRAFT INFECTIONS
I. PATHOGENESIS
II. CLINICAL PRESENTATION
III. DIAGNOSIS
IV. PREVENTION OF AORTIC GRAFT INFECTIONS
V. TREATMENT
VI. EXTRA-ANATOMIC BYPASS
VII. IN SITU REPLACEMENT WITH SUPERFICIAL FEMOROPOPLITEAL VEINS
VIII. IN SITU REPLACEMENT WITH ALLOGRAFT AND ANTIBIOTIC-TREATED PROSTHETIC GRAFTS
IX. ALTERNATIVE APPROACHES TO REMOVING THE ENTIRE AORTIC GRAFT
X. CONCLUSIONS
REFERENCES
18: DETECTION AND MANAGEMENT OF FAILING AUTOGENOUS GRAFTS
I. ETIOLOGY OF AUTOGENOUS GRAFT FAILURE
II. PERIOPERATIVE FAILURE
III. POSTOPERATIVE FAILURE
IV. GRAFT SURVEILLANCE PROTOCOL
V. TECHNIQUE
VI. LONG-TERM CHANGES IN AUTOGENOUS GRAFTS
VII. EFFECT OF SITE OF DISTAL ANASTOMOSIS
VIII. EFFECT OF VEIN GRAFT DIAMETER AND DIABETES MELLITUS
IX. OPERATIVE MANAGEMENT OF THE PATENT BUT FAILING AUTOGENOUS GRAFT
X. SECONDARY PROCEDURES FOR REVISION OF THE FAILING AUTOGENOUS GRAFT
XI. PERIOPERATIVE RESULTS OF MANAGEMENT OF THE PATENT BUT FAILING AUTOGENOUS GRAFT
XII. FACTORS THAT AFFECT THE LONG-TERM PATENCY RATE OF AUTOGENOUS GRAFTS
XIII. CONCLUSION
REFERENCES
19: AN APPROACH TO TREATMENT OF INF RAINGUINAL GRAFT OCCLUSIONS
I. PREVENTION OF POSTOPERATIVE GRAFT OCCLUSION
II. TREATMENT OF ACUTE POSTOPERATIVE GRAFT OCCLUSIONS
III. TREATMENT OF LATE GRAFT OCCLUSIONS
IV. CONCLUSIONS
REFERENCES
20: WOUND COMPLICATIONS FOLLOWING VASCULAR RECONSTRUCTIVE SURGERY
I. INTRODUCTION
II. CLASSIFICATION SCHEMES
III. ETIOLOGICAL FACTORS
IV. IMPACT
V. ANATOMICAL CONSIDERATIONS AND INCIDENCE
VI. WOUND INFECTION
REFERENCES
21: COMPLICATIONS IN THE MANAGEMENT OF THE DIABETIC FOOT
I. ANTIBIOTIC THERAPY
II. WOUND CARE
III. CASE MANAGEMENT
REFERENCES
22: COMPLICATIONS OF LOWER EXTREMITY AMPUTATION
I. INTRODUCTION
II. MORTALITY
III. WOUND HEALING FAILURE
IV. INFECTION
V. PHANTOM LIMB PAIN
VI. FLEXION CONTRACTURES
VII. INABILITY TO AMBULATE
VIII. DEEP VENOUS THROMBOSIS/PULMONARY EMBOLISM
IX. LONG-TERM OUTLOOK
X. SUMMARY AND RECOMMENDATIONS
REFERENCES
23: COMPLICATIONS OF VASCULAR ACCESS
I. TEMPORARY ACCESS
2. BLEEDING
II. PERIPHERAL ACCESS
III. USE OF DIALYSIS HISTORY AND PHYSICAL EXAMINATION
IV. THE FAILING FISTULA
V. CONCLUSION
REFERENCES
24: COMPLICATIONS OF THORACIC OUTLET SURGERY
I. INTRODUCTION
II. ANATOMY
III. OPERATIONS
IV. COMPLICATIONS
V. CONCLUSIONS
REFERENCES
25: STROKE AS A COMPLICATION OF NONCEREBROVASCULAR SURGERY
I. STROKE DEMOGRAPHICS
II. ETIOLOGY OF STROKE
III. RISK FACTORS FOR STROKE
IV. STROKE IN NONCEREBROVASCULAR SURGERY
V. MINIMIZING PERIOPERATIVE STROKE
VI. CONCLUSION
REFERENCES
26: COMPLICATIONS OF REPAIR OF THE SUPRA-AORTIC TRUNKS AND THE VERTEBRAL ARTERIES
I. INTRODUCTION
II. EXTRA-ANATOMICAL REPAIRS OF THE SUPRA-AORTIC TRUNKS
III. ASCENDING AORTIC OPERATIONS—INNOMINATE ARTERY ATHEROSCLEROSIS
IV. DIRECT VERTEBRAL ARTERY RECONSTRUCTION
REFERENCES
27: PREVENTION OF TRANSIENT ISCHEMIC ATTACKS AND ACUTE STROKES AFTER CAROTID ENDARTERECTOMY: A CRITIQUE OF TECHNIQUES FOR CEREBROVASCULAR PROTECTION DURING CAROTID ENDARTERECTOMY
I. TEMPORARY INDWELLING SHUNT
II. AVOIDANCE OF INTRAOPERATIVE EMBOLIZATION
III. THE TECHNICALLY PERFECT OPERATION
IV. CORRECTION OF NEUROLOGICAL DEFICITS
V. CONCLUSION
REFERENCES
28: NONSTROKE COMPLICATIONS OF CAROTID ENDARTERECTOMY
I. NEUROLOGICAL COMPLICATIONS
II. NONNEUROLOGICAL COMPLICATIONS
III. CONCLUSIONS
REFERENCES
29: RADIATION EXPOSURE AND CONTRAST TOXICITY
I. RADIATION EXPOSURE
II. CONTRAST TOXICITY
REFERENCES
30: COMPLICATIONS IN PERIPHERAL THROMBOLYSIS
I. BIOCHEMISTRY OF THROMBOLYTIC AGENTS
II. SAFETY OF THROMBOLYTIC AGENTS IN CLINICAL TRIALS
III. PREVENTING HEMORRHAGE DURING THROMBOLYSIS: POTENTIAL FOR THE FUTURE
IV. NONHEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC AGENTS
V. SUMMARY AND CONCLUSIONS
REFERENCES
31: COMPLICATIONS OF SCLEROTHERAPY
I. INTRODUCTION
II. PRINCIPLES OF SCLEROTHERAPY
III. SCLEROTHERAPY COMPLICATIONS
REFERENCES
32: COMPLICATIONS OF SUBFASCIAL ENDOSCOPIC PERFORATOR VEIN SURGERY AND MINIMALLY INVASIVE VEIN HARVESTS
I. SUBFASCIAL ENDOSCOPIC PERFORATOR VEIN SURGERY
II. ENDOSCOPIC SAPHENOUS VEIN HARVESTING
REFERENCES
33: COMPLICATIONS OF VENOUS ENDOVASCULAR LYSIS AND STENTING (ILIAC, SUBCLAVIAN)
I. COMPLICATIONS RELATED TO VENOUS CANNULATION
II. COMPLICATIONS RELATED TO LYSIS OF DEEP VEIN THROMBOSIS
III. COMPLICATIONS RELATED TO STENTING OF ILIOFEMORAL VENOUS OUTFLOW CHANNEL
IV. COMPLICATIONS RELATED TO STENTING OF THE SUBCLAVIAN VEIN
V. COMPLICATIONS RELATED TO STENTING OF THE SUPERIOR VENA CAVA
REFERENCES
34: COMPLICATIONS OF ENDOVASCULAR INTERVENTION FOR AV ACCESS GRAFTS
I. INTRODUCTION
II. ENDOVASCULAR INTERVENTIONS
III. COMPLICATIONS OF ENDOVASCULAR INTERVENTIONS
IV. SUMMARY
REFERENCES
35: COMPLICATIONS OF VENA CAVA FILTERS
I. INTRODUCTION
II. INDICATIONS
III. DEVICES IN USE TODAY
IV. COMPLICATIONS
V. PREVENTING AND CORRECTING VENA CAVA FILTER COMPLICATIONS
VI. CONCLUSION
REFERENCES
36: COMPLICATIONS OF PERCUTANEOUS TREATMENT OF ARTERIOVENOUS MALFORMATIONS
I. TYPES OF VASCULAR ANOMALIES
II. EMBOLIZATION TECHNIQUES
III. SPECIFIC EMBOLIC AGENTS AND PROBLEMS RELATED TO THEIR USE
IV. COMPLICATIONS ASSOCIATED WITH SPECIFIC ANATOMIC REGIONS
REFERENCES
37: ENDOVASCULAR COMPLICATIONS OF ANGIOPLASTY AND STENTING
I. PROCEDURE SITE COMPLICATIONS
II. ARTERIAL PERFORATION
III. ARTERIAL DISSECTION
IV. ARTERIAL THROMBOSIS
V. ARTERIAL SPASM
VI. EQUIPMENT FAILURE
VII. DEVICE EMBOLIZATION
VIII. CONCLUSION
ACKNOWLEDGMENT
REFERENCES
38: COMPLICATIONS OF CAROTID STENTING
I. INTRODUCTION
II. PROCEDURAL COMPLICATIONS
III. POSTPROCEDURAL
IV. LATE EVENTS
V. CONCLUSIONS
REFERENCES
39: ENDOVASCULAR ACCESS COMPLICATIONS
I. ACCESS FAILURE
III. HEMODYNAMIC COMPROMISE
IV. CONCLUSION
REFERENCES
40: DEVICE FAILURE
I. INTRODUCTION
II. BACKGROUND
III. MODES OF FAILURE
IV. ETIOLOGY OF FAILURE
V. CLINICAL SIGNIFICANCE
VI. CONCLUSION
REFERENCES
41: ENDOLEAK
I. INTRODUCTION
II. ENDOLEAK TYPES
III. DIAGNOSIS OF ENDOLEAK
IV. TIME OF ENDOLEAK OCCURENCE
V. AVOIDING ENDOLEAK
VI. MANAGEMENT OF ENDOLEAKS
VII. A VIEW TOWARD THE FUTURE OF ENDOLEAK
ACKNOWLEDGMENT
REFERENCES
42: COMPLICATIONS FOLLOWING ENDOVASCULAR THORACIC AORTIC ANEURYSM REPAIR
I. ANATOMICALLY RELATED COMPLICATIONS
II. DEVICE-RELATED COMPLICATIONS
III. SUMMARY
REFERENCES
43: COMPLICATIONS OF ANGIOGENESISTHERAPY
I. INCREASED VASCULAR PERMEABILITY
II. HYPOTENSION
III. VASCULAR MALFORMATIONS
IV. RETINOPATHY
V. NEPHROTOXICITY
VI. NEOPLASIA
VII. ATHEROSCLEROSIS
VIII. COMPLICATIONS ASSOCIATED WITH VIRAL VECTORS
IX. MORTALITY
X. CONCLUSIONS
vascular injuries and complications in orthopedic surgery procedures
vascular surgery topics
is vascular surgery dangerous
what are the main complications with vascular surgeries
is vascular surgery a major surgery